BCMLT
IMCR icon

Beacon Capital Management LLC (Tennessee)’s Immunocore IMCR Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-250
Closed -$15K – 1016
2023
Q3 		$15K Hold
250
– – ﹤0.01% 463
2023
Q2 		$15K Hold
250
– – ﹤0.01% 463
2023
Q1 		$12.4K Hold
250
– – ﹤0.01% 453
2022
Q4 		$14.3K Hold
250
– – ﹤0.01% 432
2022
Q3 		$9K Hold
250
– – ﹤0.01% 496
2022
Q2 		$7K Hold
250
– – ﹤0.01% 580
2022
Q1 		$7K Buy
+250
New +$6.31K ﹤0.01% 580

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s IMCR Position: Q4 2023 in Review

Beacon Capital Management LLC (Tennessee) sold out of Immunocore (IMCR) in Q4 2023, closing a stake of 250 shares — an estimated $15K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in IMCR in Q1 2022 and held it in 7 quarters. The position peaked at $15K in Q3 2023. 133 funds tracked by Wall St. Rank hold IMCR as of Q4 2023.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Immunocore position as of Q4 2023 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 250 Immunocore shares in Q4 2023, an estimated $15K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Immunocore in Q1 2022 and held it in 7 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Immunocore position peaked at $15K in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Immunocore as of Q4 2023.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q4 2023, filed 9 Jan 2024.